VEXAS综合征的眼部特征:系统综述与荟萃分析
该系统综述与荟萃分析纳入52篇文章共204例经基因确诊的VEXAS综合征患者,分析其眼部特征,发现眶周水肿最常见(40.7%),剪接位点突变组较甲硫氨酸41错义突变组眼部特征更严重(P = .04),作者建议出现眼部症状的VEXAS患者接受眼科检查。
要点
- VEXAS综合征眼部表现多样,眶周水肿最常见(n = 83,40.7%),其次为巩膜外层炎和巩膜炎(各n = 28,13.7%)。
- 剪接位点突变组较甲硫氨酸41错义突变组眼部特征更严重(P = .04)。
- 作者建议出现眼部症状的VEXAS患者接受眼科检查,因存在威胁视力的疾病风险。
核心结论
- VEXAS综合征的眼部特征存在显著差异,作者建议出现眼部症状的VEXAS患者接受眼科检查,因存在威胁视力的疾病风险。
研究设计与样本
- 遵循PRISMA指南的系统文献综述与荟萃分析(PROSPERO注册号:ID 566167),检索PubMed/MEDLINE、Embase和CENTRAL数据库2020年1月至2024年9月的文献。
- 纳入标准为经基因确诊的VEXAS综合征且报告眼部受累;排除标准为缺乏基因检测或未报告眼部特征。
- 共纳入52篇文章,合计204例个体(其中1例女性);荟萃分析纳入32篇文章(n = 48)含基因型与眼部特征数据。
- 采用Kruskal-Wallis秩和检验和Fisher精确检验分析眼部特征严重程度与年龄或致病突变之间的关联。
主要发现
- VEXAS症状平均发病年龄为67 ± 5岁(范围:46-87岁)。
- 眶部炎症是最常见的眼部表现,包括眶周水肿(n = 83,40.7%)、眶肌炎(n = 14,6.9%)、泪腺炎(n = 6,2.9%)和眶间隔综合征(n = 1,0.5%)。
- 其他眼部特征包括巩膜外层炎(n = 28,13.7%)、巩膜炎(n = 28,13.7%)、葡萄膜炎(n = 25,12.3%)和视网膜血管炎(n = 2,1%)等。
- 视力报告有限(n = 4,2%)。
- 荟萃分析中最常见的UBA1突变为错义突变p.Met41Thr(n = 24,50%),其次为p.Met41Val(n = 17,35%)、p.Met41Leu(n = 4,8%)和剪接位点突变或缺失(n = 3,6%)。
关键数值与推荐
- VEXAS综合征眼部表现中眶周水肿最常见(n = 83,40.7%),其次为巩膜外层炎和巩膜炎(各n = 28,13.7%)、葡萄膜炎(n = 25,12.3%)。
- 剪接位点突变组较甲硫氨酸41错义突变组眼部特征更严重(P = .04)。
- 最常见的UBA1突变为p.Met41Thr(n = 24,50%),其次为p.Met41Val(n = 17,35%)、p.Met41Leu(n = 4,8%)和剪接位点突变或缺失(n = 3,6%)。
临床怎么用
- 作者建议出现眼部症状的VEXAS患者接受眼科检查,因存在威胁视力的疾病风险。
局限性
- 视力报告有限(n = 4,2%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify and analyze ocular features seen in Vacuoles, E1-ligase, X-linked Auto-inflammatory, Somatic (VEXAS) syndrome. DESIGN: A systematic literature review was performed following PRISMA guidelines (PROSPERO registration number: ID 566167). METHODS: Article inclusion criteria comprised genetic confirmation VEXAS syndrome that included eye involvement. Exclusion criteria included lack of genetic testing, or ocular feature reporting. A systematic search of the PubMed/MEDLINE, Embase, and CENTRAL databases was performed from January 2020 to September 2024. Data were collected and risk of bias assessed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. For the meta-analysis, specific UBA1 mutation and systemic feature data were also included. An association between severity of ocular features, presence of specific ophthalmic or systemic features, with age or causative mutation was investigated using Kruskal-Wallis rank sum testing and Fisher exact test, respectively, using R. RESULTS: Fifty-two articles were included, amounting to 204 individuals (1 female). Mean age of VEXAS symptom onset was 67 ± 5 years (range: 46-87). Orbital inflammation was the most common ocular manifestation, comprising periorbital edema (n = 83, 40.7%), orbital myositis (n = 14, 6.9%), dacryoadenitis (n = 6, 2.9%), and orbital compartment syndrome (n = 1, 0.5%). Other features included episcleritis (n = 28, 13.7%), scleritis (n = 28, 13.7%), uveitis (n = 25, 12.3%), and retinal vasculitis (n = 2, 1%), among others. Visual acuity reporting was limited (n = 4, 2%). Meta-analysis was conducted on 32 articles (n = 48) with genotype and ocular feature data. The most commonly reported UBA1 mutation was the missense mutation p.Met41Thr (n = 24, 50%), followed by p.Met41Val (n = 17, 35%), p.Met41Leu (n = 4, 8%), and splice site mutations or deletions (n = 3, 6%). There was an association for more severe ophthalmic features in the splice site mutation group vs methionine 41 missense mutations (P = .04). The most commonly associated systemic features included dermatologic manifestations (n = 41, 85%), recurrent fever (n = 38, 79%), and pulmonary involvement (n = 30, 63). CONCLUSION: There is notable variation in the ophthalmic features of VEXAS. Ophthalmic review is advised for VEXAS patients who develop eye symptoms, given the risk of sight-threatening disease.
引用
- Quigley C, Pietris J, Ang T, et al. Ocular Features of VEXAS Syndrome: A Systematic Review and Meta-analysis. Am J Ophthalmol. 2025. PMID: 40157447. doi:10.1016/j.ajo.2025.03.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。